KLOW vs GLOW vs Wolverine Stack Feature Components Wolverine Stack BPC-157 + TB-500 GLOW Stack GHK-Cu + BPC-157 + TB-500 KLOW Blend GHK-Cu + KPV + BPC-157 + TB-500 Feature Total vial mass (typical) Wolverine Stack 10-20 mg GLOW Stack 70 mg KLOW Blend 80 mg Feature Primary research focus Wolverine Stack Soft-tissue repair GLOW Stack Skin + tissue + recovery KLOW Blend Skin + tissue + anti-inflammatory Feature Adds KPV (anti-inflammatory) Wolverine Stack No GLOW Stack No KLOW Blend Yes Feature Adds GHK-Cu (collagen / gene expression) Wolverine Stack No GLOW Stack Yes KLOW Blend Yes Feature Number of injections Wolverine Stack 1 GLOW Stack 1 KLOW Blend 1 These are the most common community framings
A commonly used regimen is a loading phase of 25 mg per week (subcutaneous injection) for 46 weeks, followed by a maintenance dose of around 2 mg every 12 weeks
Whistler JL, Chuang HH, Chu P, Jan LY, von Zastrow M: Functional dissociation of mu opioid receptor signaling and endocytosis: Implications for the biology of opiate tolerance and addiction
Correlations between gene modules and experimental conditions (genotype or treatment) were tested using the limma R package, with multiple testing corrections via the BenjaminiHochberg method
The primer pairs used for exon amplification (exons 1 to 8) of both the tumor and normal tissue and DNA sequencing with a 3730XL DNA analyzer (Thermo Fisher Scientific, MA USA) were performed as previously reported 6
H2AX tyrosine phosphorylation has also been shown to hinder histones capacity to interact with DNA repair effectors following DSBs
